Despite increased orders and the public’s unprecedented rush to get vaccinated, influenza vaccination rates did not increase during the fall and winter of 2020-2021—in fact, the numbers are down in most of the age groups measured.
Alberta has become the third province in Canada to fund the Fluzone High-Dose influenza vaccine for all adults aged 65 and older, beginning with 2021-2022 season.
Sanofi will build a new vaccine manufacturing facility in Toronto, Ontario, to increase the supply of its Fluzone High-Dose quadrivalent influenza vaccine in Canada, the U.S. and Europe.
The World Health Organization (WHO) has released its recommendations for the composition of vaccines for the 2021-2022 flu season, working with record-low levels of surveillance data from the 2020-2021 season.
